Ogino, Ken <br/><br/>
Intravitreal injection of ranibizumab for recovery of macular function in eyes with subfoveal polypoidal choroidal vasculopathy.  [electronic resource] 

 -  Investigative ophthalmology & visual science  May 2013 
 - 3771-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1552-5783 
<br/><br/><label>Standard No.: </label>10.1167/iovs.12-11494  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Choroid--blood supply<br/>Choroid Diseases--drug therapy<br/>Female<br/>Fovea Centralis--drug effects<br/>Humans<br/>Intravitreal Injections<br/>Macula Lutea--drug effects<br/>Macular Edema--drug therapy<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Ranibizumab<br/>Recovery of Function--drug effects<br/>Retinal Detachment--drug therapy<br/>Treatment Outcome<br/>Visual Acuity--drug effects<br/>Visual Field Tests